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Aim. To study the -synuclein (ASN) aggregates of different structural origin, namely amyloid fibrils and sphe-
rical oligomers, in comparison with a native protein. Methods. MALDI TOF mass spectrometry and atomic for-
cemicroscopy(AFM).Results.ThemassspectraofnativeandfibrillarASNhavesimilarcharacter,i.e.theyare
characterized by the well pronounced peak of protein molecular ion, the low molecular weight associates, and
ratherlowcontainoffragmentationproducts.Thespectrumofoligomericaggregateischaracterizedbythehigh
contain of fragmentation products, low intensity of protein molecular ion and the absence of peaks of associates.
Conclusions. The difference between the spectra of fibrillar and oligomeric ASN could be explained, first, by the
different content of the «residual» monomeric ASN and the protein degradation products in the studied samples,
and, second, by the different structure-depended mechanisms of the protein degradation induced by the laser ioni-
zation. We suggested that the MALDI-TOF mass spectroscopy is a method useful for the investigation of ASN ag-
gregationandcharacterizationofitshighorderself-associates;besides,thereisaninterestinestimatingthepo-
tency of the MALDI-TOF for the analysis of aggregation of various amyloidogenic proteins.
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Introduction.Pathogenesis ofsomeharmfuldisorders
among them neurodegenerative disorders (Parkinson,
Alzheimer’s diseases), prion diseases, type II diabetes
isassociatedwiththespontaneousuncontrolledprotein
aggregation,particularlywiththeformationofamyloid
fibrils.Besides,a widerangeofproteins,notinvolvedin
a certain disease, are able to form amyloid aggregates
[1]. Thefore, the study on the protein aggregation is an
actual biomedical task.
AmongthemethodsofproteinanalysistheMALDI-
TOF mass spectrometry is known as a popular and ver-
satiletool [2]. In theproteomics, particularly in thestu-
dies on protein non-controlled aggregation, MALDI-
TOF is mostly applied for the identification of protein
origin by a proteolysis-based mass mapping method
[3, 4].
The method of direct (excluding proteolysis diges-
tion) MALDI-TOF has a low descriptiveness for the
characterization of the protein high-molecular aggre-
gates and was applied to analyze the fibrillization in-
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ta-lactoglobuline dimers and protein degradation pro-
ducts [5].
Alpha-synuclein (ASN) is a small natively unfolded
proteinthatplaysacentralroleintheetiologyofParkin-
son’s disease. It forms amyloid fibrils that are found in
Lewy bodies, i. e. cell depositions in the brain that are
characteristic of this disease [6, 7]. Besides, during the
aggregationprocessASNformssmalloligomericinter-
mediates, which are considered as presumably toxic
species [8–10].
Here we report the examination of the ASN aggre-
gates populations of different structural origin, namely
amyloid fibrils and spherical oligomers, by the method
ofMALDI-TOFmassspectrometry.Wesuggestthatthe
filamentous amyloid fibrils and spherical oligomers due
to the distinct folding of the protein molecules and asso-
ciation/degradation on the aggregation pathway could
possess the mass spectra of different character. Besides,
we intend to evaluate the applicability of MALDI-TOF
as a method for the analysis of protein aggregates and
study on the aggregation process.
Materials and methods. Reagents. Recombinant
human wild-type ASN was expressed and purified in
10mMTris-HCl,50mMNaCl(pH7.4)asdescribedear-
lier[11]. ASNamyloidfibrilsandoligomerswereobtai-
ned according to [11] and [12] correspondingly.
MALDI-TOF studies. The samples of native, fibril-
lar and oligomeric ASN were prepared for the MALDI-
TOF analysis as follows: matrix material (12 mg of 3,
5-dimethoxy-4-hydroxycinnamic (sinapinic) acid) was
dissolved in 1 ml of water/acetonytyl solution 1:1 (v/v)
with addition of 0.1 % (v/v) of trifluoroacetic acid. The
obtainedsolutionwasincubatedduring10minat30°C
in ultrasonic bath up to the full dissolving of the acid.
[13]. The 50 µmol protein samples in 0,05 M Tris-HCl
buffer (pH 7.9) with concentration of 1mg/ml were
thenaddedtothematrixsolutionin1:1ratio. Smallali-
quotsof themixturewereappliedtothesteelprobetips
and dried. Mass analysis was performed on the «Auto-
flex II» («Bruker Daltonics», Germany) MALDI-TOF
mass spectrometer with nitrogen laser ( = 337 nm).
Spectra were obtained for the mass range 7 000 to 100
000 m/z. in positive ion reflectron registration mode.
The spectra were obtained by summing the data of 100
laser shots.
Atomic force microscopy studies. The structure of
ASN aggregates was studied by means of AFM («Sol-
ver Pro M» system, NT-MDT, RF). The scanning rate
was30m/s. Fortheformationofsubnanolayer consis-
ting of separate nanoobjects, the reaction solutions we-
re diluted 30 times with bidistilled water. Then a drop
ofthesolutionwasappliedonthefreshlycleavedsurfa-
ceofmica.TheAFMmeasurementswerecarriedoutin
a tapping mode at ambient conditions after the full eva-
porationofthesolvent.TheAFMprobesoftypeNSG01
(NT-MDT) were used. The average diameter values of
ASN aggregates were determined based on their heights
in the AFM images.
Results and discussion. Structural peculiarities of
native, fibrillar and oligomeric ASN. ASN is a small
(140 amino acids) protein that is known to be natively
unfoldedinsolutions.Theprotein'saminoacidsequen-
ceconsistsofabasicN-terminalregion(residues1–95)
containing repeats of highly conserved KTKEGV hexa-
meric motif, and an acidic C-terminal region (residues
96–140) [14], the first 100 residues are predicted to ha-
ve-helical propensity [15].
Amyloid fibrils are stable protein aggregates, with
cross-filament structure where the protein molecules,
making up the -sheet, are arranged perpendicular to
the fibril axis [16]. The core of the ASN fibril contains
mainly the protein residues of the basic region (appro-
ximately residues 38–95 [17]). We have estimated the
characteristics of the ASN fibrils population by AFM.
Thesefibrilsareboth linearand branched long filaments
with thediameterofsinglefilamentabout3–8 nm(Fig.
1).Thebundlesoffibrilsformedby overlappingofsing-
lefilamentswereobservedinthestudiedsampleaswell.
The strong fluorescent sensitivity of the amyloid-
specific cyanine dye 7519 to the ASN fibrils was pre-
viously reported [18].
The ASN oligomers are known as spherical protein
aggregatesofthesize intherange2–20nm[19–21],be-
sides, the structures with annular and tubular morpho-
logy have also been reported [21–23].
Our AFM study demonstrated the ASN oligomer
population to be mostly the species of the height from 3
till 6 nm (Fig. 2). Besides, the structures formed due to
the coalescence of these aggregates are observed; the
diameter of such «super-oligomeric» structures being
up to 10 nm.
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Despite the oligomer aggregates are mainly consi-
dered to possess beta-sheet structure [24, 25], the pre-
sence of-helical content has been shown as well [19].
The difference between the secondary structure motifs
of amyloid fibrils and oligomeric aggregates is indi-
cated by the different sensitivity of amyloid-specific
cyanine dyes to these ASN formations [26]. The noti-
ceably lower fluorescent response of the dyes on the
presence of oligomers comparing to fibrils is explained
by the lower content of beta-pleated regions accessible
for the dye molecules.
MALDI-TOF studies. The mass spectra of native,
fibrillar and oligomeric ASN are presented in Fig. 3.
All spectra contain the peaks corresponding to the pro-
teinmolecularionabout14460m/zand awiderangeof
proteinfragmentationpeaks,butonlytwoofthesepeaks
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Fig. 1. AFM image of amyloid fibril of ASN (a) and Z-profile along the line marked on the image (b)
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Fig. 2. AFM image of oligomer aggregates of ASN (a) and Z-profile along the line marked on the image (b)(about13720and10630m/z)arecommonforallprotein
forms.
The peaks corresponding to low-order associates
were detected only for native and fibrillar ASN. Thus, we
suggest that the protein mass-spectra depend on its
association degree and folding type (native ASN, oligo-
mer or fibril).
Molecularionandproteinassociates.
In the mass spectrum of native ASN the molecular ion
peak with molecular mass about14460 m/z is the most
intensive and highly resolved, it contains satellite shoul-
der corresponding to an associate of ASN molecule with
the matrix one (sinapic acid). The mass spectrum is cha-
racterized by insignificant content of the protein frag-
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Fragment Mass, m/z
Native Oligomer Fibril
I,a .u . I,a .u . I,a .u .
[5M]
+ 72170 280 – –
[4M]
+ 57720 734 – –
[3M]
+ 43260 2234 – 739
[2M]
+ 28860 9808 – 2681
[M]
+ 14460 66459 1672 40648
F1 13720 6441 1167 9148
F2 10630 3379 3427 8407
N o t e. Mass – observed mass of the peaks; I – intensity of peaks; a. u. – arbitrary units; [M]
+ – molecular ion; [nM]
+ (where n = 2–5) – molecular
associates of ASN containing n protein molecules; F1 and F2 – fragments that are common for all protein forms.
Table 1
Protein fragments and associates observed in mass spectra of native and aggregated ASN
Fragment (Forme) I [M]
+/I[M]
+ – [1–40] I [M]
+/I[M]
+ – [1–7] [M]
+ [2M]
+ [3M]
+ [4M]
+ [5M]
+
Native 0.05 0.09 1 0.14 0.03 0.01 0.004
Oligomer 2.04 2.04 1
Fibril 0.20 0.22 1 0.06 0.02
Table 2
Ratio between intensities of ASN fragments and molecular ion peaks
m/z
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Fig. 3. General mass spectrum of native (a), oligomeric (b) and fibrillar (c)A S Nmentation products. The series of peaks with the inten-
sities decreasing upon the mass increase are detected in
thehighmassregion;theycorrespondtotheproteinmo-
lecularassociatesfromdimertopentamerwithmolecu-
lar masses about 28860, 43260, 57720 and 72170 m/z,
correspondingly (Table 1, 2). The association is caused
by intermolecular interactions and is typically obser-
ved in the MALDI-TOF mass spectra of different pro-
teins(albumin,insulin,lysozimeetc.)[4,13],theforma-
tionofASNdimer,trimerandtetramerwasalsodescri-
bed [15].
Inthe fibrillarproteinspectrum,similarlytothatof
thenativeASN,thepeakofmolecularionisthemostin-
tensive. The low order associates are also presented in
the spectrum, but the number of aggregated molecules
(onlydimersandtrimerswereobserved)andintensityof
peaks are lower than for the native protein. On the other
hand,thenumberandintensity of thepeaksoffragmen-
tationproductsforthefibrillarASNisenhancedascom-
pared to the native protein.
The mass spectrum of oligomer significantly differs
from that of native and fibrillar protein. It is characteri-
zed by a very high fragmentation degree (the peak of
molecular ion is less intensive than the main peaks of
fragmentation products) and by the absence of associa-
tes peaks.
Thefragmentationproducts.Inthem ass
spectrum of the native, fibrillar and oligomeric ASN the
widerangeofproteinfragmentationproductisdetected
(Fig.4,Table1,2).However,onlytwoofthemwithmo-
lecular masses about 13720 and 10630 m/z (F1 and F2
correspondingly), are common for all protein forms.
Thecontent of fragmentation productsin thenative
ASN mass spectrum is quite low, the peaks with m/z of
about 13980, 13720, 10830 and 10630 correspond to
the major fragmentation products of ASN molecule.
In the case of fibrillar ASN the content of protein
fragmentationproductsismuchhigherthaninthemass
spectrumofnativeprotein,themajorpeakswithm/z of
about 13720, 12950, 11870, 10830, 10630, 9680 and
9300 were detected.
In the oligomeric ASN spectrum the wide poorly re-
solved bands of protein fragmentation products domi-
nate. Thetwo peaksof about 11130m/z and 13980 m/z
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Fig. 4. Representative mass spectra of native (a), oligomeric (b) and fibrillar ASN (c) in molecular mass region 9000–15000 m/z
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Fig. 5. Sequence of human ASN (from uniprot.db, entry P37840)are twice more intensive than this of the molecular ion
of ASN. Another intensive peak of about 10630 m/z is
also present in the spectra of native and fibrillar ASN.
The fragment with m/z about 13720 that is common for
allproteinformshaslowintensityinspectraofoligome-
ric aggregate.
Explanations of a distinct character of the fibrillar
and oligomeric ASN mass-spectra. We could propose
twoexplanationsofthedistinctionsinthemass-spectra
of fibrillar and oligomeric ASN.
The first explanation i st h a tt h es i m i l a r i t y
ofthenativeandfibrillarASNmassspectaiscausedby
the presence of an excess of non-aggregated protein in
the fibrillar ASN sample. Since the ASN monomeric
molecules are easily ionized they give a high intensive
peak of the molecular ion and associates.
Thedistinctionbetweenthefragmentationoffibrils
and oligomers could be caused by the presence of spe-
cific degradation products formed during the aggrega-
tion reaction or later storage of the samples.
Another possible explanation i sd i s -
similarityinthefoldingofproteinmoleculesintheamy-
loid fibrils and the oligomeric species and different struc-
ture of these aggregates.
It may be supposed that due to their regular ladder-
likestructurethedegradationoftheamyloidfibrilsupon
ionization in a large extent occurs through the tearing
off the intact protein molecules fromthe end (one by one)
of the filament. These protein molecules are responsib-
leforanintensivepeakofthemolecularionandpeaksof
the low-ordered associates.
Besides, the laser-induced degradation could occur
throughabreakin theproteinchain,thatleadstotheap-
pearance of new intensive bands of the protein frag-
mentation products. This mechanism is proved by high-
er number, content and lower resolution of the protein
fragment peaks in the spectrum of fibrils comparing
with the native ASN.
The large content of fragmentation products in the
spectrum of the oligomeric aggregates and their low
resolution may be explained by the poor ionization and
poor stability ofthesestructures.Weassumethatdueto
their spherical shape the oligomeric aggregates degra-
ded through the lost of protein fragments from the ope-
ned surfaceregions. Thesuggestion about thehindered
ability ofdegradationoftheoligomericaggregatethrough
thetearingoffawholeproteinmoleculeissupported by
the very low intensity of molecular ion.
Î. Â. Ñåâåðèíîâñüêà, Â. Á. Êîâàëüñüêà, Ì. Þ. Ëîñèöüêèé,
Â. Â. ×åðåïàíîâ, Â. Ñóáðàìàí³àì, Ñ. Ì. ßðìîëþê
Âèêîðèñòàííÿ ìåòîäó MALDI-TOF ìàññ-ñïåêòðîìåòð³¿ äëÿ
âèâ÷åííÿ ô³áðèëÿðíèõ òà îë³ãîìåðíèõ àãðåãàò³â àëüôà-ñèíóêëå¿íó
Ðåçþìå
Ìåòà.Âèâ÷åííÿàãðåãàò³âàëüôà-ñèíóêëå¿íó(ASN)ð³çíîãîñòðóê-
òóðîâîãî ïîõîäæåííÿ, à ñàìå – àì³ëî¿äíèõ ô³áðèë ³ ñôåðè÷íèõ
îë³ãîìåð³â ïîð³âíÿíî ç íàòèâíèì á³ëêîì. Ìåòîäè. MALDI-TOF
ìàñ-ñïåêòðîìåòð³ÿ òà àòîìíî-ñèëîâà ì³êðîñêîï³ÿ (ÀFÌ). Ðå-
çóëüòàòè. Ìàñ-ñïåêòðè íàòèâíîãî ³ ô³áðèëÿðíîãî ASN ìàþòü
ïîä³áíèé õàðàêòåð – äëÿ íèõ õàðàêòåðí³ ³íòåíñèâíèé ï³ê ìîëåêó-
ëÿðíîãî³îíàá³ëêà,ï³êèíèçüêîìîëåêóëÿðíèõàñîö³àòîâòàäîñèòü
íåçíà÷íèé âì³ñò ïðîäóêò³â ôðàãìåíòàö³¿ á³ëêà. Ó òîé æå ÷àñ ó
ñïåêòð³ îë³ãîìåðíèõ àãðåãàò³â ñïîñòåð³ãàþòüñÿ âèñîêà êîíöåíò-
ðàö³ÿïðîäóêò³âôðàãìåíòàö³¿á³ëêà, íèçüêà³íòåíñèâí³ñòüìîëåêó-
ëÿðíîãî ³îíà òà â³äñóòí³ñòü ï³ê³â ñàìîàñîö³àò³â. Âèñíîâêè.Ð ³ ç -
íèöþ ì³æ ñïåêòðàìè ôèáðèëÿðíîãî òà îë³ãîìåðíîãî ASN ìîæíà
ïîÿñíèòè ÿê íàÿâí³ñòþ ó çðàçêàõ «çàëèøêîâîãî» ASN ³ ïðîäóêò³â
äåãðàäàö³¿ á³ëêà, òàê ³ ð³çíèìè ñòðóêòóðîâî çàëåæíèìè ìåõàí³ç-
ìàìè ðóéíóâàííÿ öèõ äâîõ âèä³â àãðåãàò³â ïðè ëàçåðí³é äåñîðá-
ö³¿/³îí³çàö³¿. MALDI-TOF ìàñ-ñïåêòðîìåòð³þ ìîæíà çàïðîïîíó-
âàòè ÿê ìåòîä âèâ÷åííÿ àãðåãàö³¿ òà àíàë³çó âèñîêîìîëåêóëÿðíèõ
àãðåãàò³â ASN. Òàêîæ ïðåäñòàâëÿº ³íòåðåñ âèçíà÷åííÿ åôåêòèâ-
íîñò³ öüîãî ìåòîäó äëÿ äîñë³äæåííÿ àãðåãàò³â ð³çíèõ àì³ëî¿äî-
ãåííèõ á³ëê³â.
Êëþ÷îâ³ ñëîâà: àëüôà-ñèíóêëå¿í, MALDI-TOF, àì³ëî¿äíà ô³áðè-
ëà, îë³ãîìåðí³ àãðåãàòè, ÀFÌ.
Î. Â. Ñåâåðèíîâñêàÿ, Â. Á. Êîâàëüñêàÿ, Ì. Þ. Ëîñèöêèé,
Â. Â. ×åðåïàíîâ, Â. Ñóáðàìàíèàì, Ñ. Í. ßðìîëþê
Èñïîëüçîâàíèå ìåòîäà MALDI-TOF ìàññ-ñïåêòðîìåòðèè
äëÿ èçó÷åíèÿ ôèáðèëëÿðíûõ è îëèãîìåðíûõ àãðåãàòîâ
àëüôà-ñèíóêëåèíà
Ðåçþìå
Öåëü. Èçó÷åíèå àãðåãàòîâ àëüôà-ñèíóêëåèíà (ASN) ðàçëè÷íîé
ñòðóêòóðû, à èìåííî – àìèëîèäíûõ ôèáðèëë è ñôåðè÷åñêèõ îëè-
ãîìåðîâ â ñðàâíåíèè ñ íàòèâíûì áåëêîì. Ìåòîäû. MALDI-TOF
ìàññ-ñïåêòðîìåòðèÿ è àòîìíî-ñèëîâàÿ ìèêðîñêîïèÿ (ÀFÌ). Ðå-
çóëüòàòû. Ìàññ-ñïåêòðû íàòèâíîãî è ôèáðèëëÿðíîãî ASN èìå-
þò ïîäîáíûé õàðàêòåð – äëÿ íèõ õàðàêòåðíû èíòåíñèâíûé ïèê
ìîëåêóëÿðíîãî èîíà áåëêà, ïèêè íèçêîìîëåêóëÿðíûõ àññîöèàòîâ,
à òàêæå äîñòàòî÷íî íåçíà÷èòåëüíîå ñîäåðæàíèå ïðîäóêòîâ
ôðàãìåíòàöèè áåëêà. Â òî æå âðåìÿ â ñïåêòðå îëèãîìåðíûõ àãðå-
ãàòîâ íàáëþäàþòñÿ âûñîêàÿ êîíöåíòðàöèÿ ïðîäóêòîâ ôðàãìåí-
òàöèè áåëêà, ìîëåêóëÿðíûé èîí íèçêîé èíòåíñèâíîñòè è îòñóò-
ñòâèå ïèêîâ àññîöèàòîâ áåëêà. Âûâîäû. Ðàçëè÷èå ìåæäó ñïåêò-
ðàìè ôèáðèëëÿðíîãî è îëèãîìåðíîãî ASN ìîæíî îáúÿñíèòü êàê
ñîäåðæàíèåì «èçáûòêà» ASN è ïðîäóêòîâ äåãðàäàöèè áåëêà,
òàê è ðàçëè÷íûìè ñòðóêòóðíî-çàâèñèìûìè ìåõàíèçìàìè ðàçðó-
øåíèÿìè ýòèõ äâóõ âèäîâ àãðåãàòîâ ïðè ëàçåðíîé äåñîðáöèè/èî-
íèçàöèè. MALDI-TOF ìàññ-ñïåêòðîìåòðèþ ìîæíî ïðåäëîæèòü
â êà÷åñòâå ìåòîäà èçó÷åíèÿ àãðåãàöèè è àíàëèçà âûñîêîìîëåêó-
ëÿðíûõ àãðåãàòîâ ASN. Òàêæå ïðåäñòàâëÿåò èíòåðåñ îïðåäåëå-
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íèå ýôôåêòèâíîñòè MALDI-TOF äëÿ èññëåäîâàíèÿ àãðåãàòîâ ðàç-
ëè÷íûõ àìèëîèäîãåííûõ áåëêîâ.
Êëþ÷åâûå ñëîâà: àëüôà-ñèíóêëåèí, MALDI-TOF, àìèëîèäíàÿ
ôèáðèëëà, îëèãîìåðíûå àãðåãàòû, ÀFÌ.
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